Adc Therapeutics SA (ADCT): Next-Year EPS Estimate 27.05%
As of 2026-06-04, Adc Therapeutics SA (ADCT) has a next-year EPS growth estimate of 27.05%.
On 2026-06-04, analyst consensus for ADCT's next-year EPS growth shifted from 27.29% to 27.05% — a negative change of 0.24 percentage points. Current-year growth is projected at 24.85%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 27.05%
- EPS growth this year
- 24.85%
- EPS next quarter (est)
- -$0.21
- Last price
- $1.47
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 27.05% | 24.85% | -$0.21 | $1.47 |
| 2026-06-03 | 27.29% | 24.11% | -$0.21 | $3.08 |
| 2026-06-02 | 27.29% | 24.11% | -$0.21 | $3.17 |
| 2026-06-01 | 27.29% | 24.11% | -$0.21 | $3.40 |
| 2026-05-31 | 27.29% | 24.11% | -$0.21 | $3.40 |
| 2026-05-28 | 27.29% | 24.11% | -$0.21 | $3.45 |
| 2026-05-27 | 27.29% | 24.11% | -$0.21 | $3.43 |
| 2026-05-26 | 27.29% | 24.11% | -$0.21 | $3.51 |
| 2026-05-25 | 27.29% | 24.11% | -$0.21 | $3.39 |
| 2026-05-24 | 27.29% | 24.11% | -$0.21 | $3.39 |
| 2026-05-21 | 27.29% | 24.11% | -$0.21 | $3.40 |
| 2026-05-20 | 27.29% | 24.11% | -$0.21 | $3.24 |
| 2026-05-19 | 27.29% | 24.11% | -$0.21 | $3.14 |
| 2026-05-18 | 27.29% | 24.11% | -$0.21 | $3.17 |
| 2026-05-17 | 27.29% | 24.11% | -$0.21 | $3.25 |
| 2026-05-14 | 27.29% | 24.11% | -$0.21 | $3.36 |
| 2026-05-13 | 27.29% | 24.11% | -$0.21 | $3.46 |
| 2026-05-12 | 27.29% | 24.11% | -$0.21 | $3.43 |
| 2026-05-11 | 27.29% | 24.11% | -$0.21 | $3.48 |
| 2026-05-10 | 27.29% | 24.11% | -$0.21 | $3.50 |
| 2026-05-07 | 27.15% | 24.26% | -$0.21 | $3.75 |
| 2026-05-06 | 27.15% | 24.26% | -$0.21 | $3.86 |
| 2026-05-05 | 27.15% | 24.26% | -$0.21 | $3.76 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Adc Therapeutics SA's next-year EPS growth estimate?▾
As of 2026-06-04, Adc Therapeutics SA (ADCT) has a next-year EPS growth estimate of 27.05%, based on analyst consensus.
When was the latest EPS estimate revision for ADCT?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 27.29% to 27.05%.
What sector and industry does Adc Therapeutics SA belong to?▾
Adc Therapeutics SA operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ADCT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Adc Therapeutics SA (ADCT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports